Kathleen Billman has extensive work experience in the pharmaceutical and biotechnology industry. Kathleen is currently working as the Executive Director of Clinical Affairs at Outlook Therapeutics, Inc. since June 2019. Prior to this role, they worked for Clearside Biomedical, Inc. as the Senior Director of Clinical Trial Management from October 2016 to June 2019.
Before joining Clearside Biomedical, Inc., Kathleen held multiple positions at Alimera Sciences. Kathleen served as the Senior Director of Scientific Affairs from April 2013 to September 2016. From October 2005 to April 2013, they worked as the Director of Scientific Affairs, and from October 2004 to October 2005, they held the position of Associate Director of Scientific Affairs.
Earlier in their career, Kathleen worked for Novartis Ophthalmics. From March 2002 to July 2004, they worked as the Principal Clinical Trial Manager. Prior to that, they served as a Senior Clinical Trial Manager from an unspecified date in 2000 to 2002.
Kathleen Billman's education history includes attending Indiana University Bloomington and East Central, although the specific start and end years, as well as any degree or field of study, are unknown. Kathleen is also certified as a member of the Association of Clinical Research Professionals, obtained in November 2001 through the institution ACRP - Association of Clinical Research Professionals.
June, 2019 - present